Testicular Cancer Treatment in Melbourne, FL

Testicular Cancer Treatment in Melbourne, FL

Early Detection Saves Lives - Board-Certified Urologists With 60+ Years of Combined Experience

Most Common In:Men ages 15-35
Cure Rate:Over 95% with early detection
Key Screening:Monthly self-examination
Primary Treatment:Orchiectomy (surgical removal)
Understanding Testicular Cancer

Understanding Testicular Cancer

The Most Common Cancer in Young Men Ages 15-35

Testicular cancer is the most frequently diagnosed solid tumor in men between the ages of 15 and 35, yet it remains one of the most treatable cancers in medicine. At Zabinski Urology in Melbourne, FL, our urologists bring over 60 years of combined urological expertise to the diagnosis and treatment of testicular cancer for patients throughout Palm Bay, Viera, Rockledge, Cocoa, Cocoa Beach, and Merritt Island.

When detected early, testicular cancer has a cure rate exceeding 95%. Understanding the warning signs and performing routine self-examinations are critical first steps. Our board-certified urologists guide patients from initial evaluation through definitive treatment, ensuring timely intervention and compassionate care at every stage.

Who Is at Risk for Testicular Cancer?

Who Is at Risk for Testicular Cancer?

Recognizing the Factors That Increase Your Likelihood

While testicular cancer can affect any male, certain factors elevate the risk. A personal or family history of testicular cancer significantly increases susceptibility. Men with cryptorchidism - an undescended testicle - carry a four- to eight-fold higher risk, even if the condition was surgically corrected in childhood.

Race also plays a role: Caucasian men are four to five times more likely to develop testicular cancer than African American men. Other contributing factors include Klinefelter syndrome, HIV infection, and prior diagnosis of carcinoma in situ (intratubular germ cell neoplasia). Infertility has also been associated with a modestly elevated risk. Importantly, there is no established link between physical trauma, athletic activity, or vasectomy and testicular cancer development.

Testicular Cancer Staging and Survival Rates

Testicular Cancer Staging and Survival Rates

Understanding How Stage Affects Treatment and Outcomes

Testicular cancer is classified into stages based on the extent of disease spread. Stage I indicates cancer confined to the testicle, with cure rates approaching 99%. Stage II involves spread to retroperitoneal lymph nodes, while Stage III indicates distant metastasis to organs such as the lungs, liver, or brain. Even in advanced stages, testicular cancer remains highly responsive to treatment, with overall survival rates exceeding 95% for all stages combined.

Tumor markers - including alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and lactate dehydrogenase (LDH) - play a critical role in staging, treatment planning, and post-treatment surveillance. At Zabinski Urology, we coordinate comprehensive staging workups including blood work, imaging, and pathology review to ensure the most accurate diagnosis and appropriate treatment pathway.

What Causes Testicular Cancer?

What Causes Testicular Cancer?

The Biology Behind Testicular Tumor Development

01

Germ Cell Mutations

Over 95% of testicular cancers arise from germ cells. Genetic mutations, particularly involving chromosome 12p (isochromosome 12p), drive uncontrolled cell division and tumor formation.

02

Cryptorchidism

An undescended testicle exposes germ cells to higher abdominal temperatures, increasing the risk of malignant transformation by four to eight times compared to normally descended testes.

03

Carcinoma In Situ (GCNIS)

Germ cell neoplasia in situ is a pre-cancerous condition present in approximately 5% of contralateral testes in men diagnosed with testicular cancer, representing a precursor to invasive disease.

04

Hormonal Factors

Prenatal estrogen exposure and disruptions in gonadal development during fetal life have been linked to testicular dysgenesis syndrome, which encompasses cryptorchidism, hypospadias, and testicular cancer.

05

Genetic Predisposition

Brothers of affected men have an 8- to 10-fold increased risk, and sons of affected fathers carry a 4- to 6-fold risk, suggesting a significant heritable component.

Why Choose Zabinski Urology for Testicular Cancer Care

Why Choose Zabinski Urology for Testicular Cancer Care

Experienced, Compassionate Urologic Oncology on the Space Coast

  • 60+ Years Combined Experience
  • Rapid Diagnostic Pathway
  • Surgical Excellence
  • Coordinated Cancer Care

Diagnostic Pathway Comparison

How We Evaluate Suspected Testicular Cancer

Procedure Best For Session Time Results Timeline Follow-Up
Cystoscopy Evaluating urinary tract symptoms that may accompany testicular conditions 15-20 minutes Immediate visual findings Based on findings
Signs You May Have Testicular Cancer

Signs You May Have Testicular Cancer

When to See a Urologist Immediately

  • Painless Testicular Lump
  • Testicular Swelling or Enlargement
  • Dull Ache in the Lower Abdomen or Groin
  • Scrotal Pain or Discomfort
  • Change in Testicular Firmness or Texture
  • Breast Tenderness or Swelling

Frequently Asked Questions About Testicular Cancer

01 How do I perform a testicular self-examination?

Perform the exam during or after a warm shower when the scrotal skin is relaxed. Gently roll each testicle between your thumb and fingers, feeling for any hard lumps, smooth bumps, or changes in size, shape, or consistency. The epididymis (a soft, tube-like structure behind the testicle) is normal. Report any new findings to your urologist immediately.

02 Does testicular cancer always require surgery?

Yes. Radical inguinal orchiectomy - the surgical removal of the affected testicle through a groin incision - is the standard first-line treatment for nearly all testicular cancers. It serves both a diagnostic and therapeutic purpose, providing definitive pathology while removing the primary tumor.

03 Will I still be able to have children after treatment?

Most men with one healthy testicle maintain normal fertility and testosterone production. However, we strongly recommend sperm banking before surgery, as some patients may require additional treatments (chemotherapy or radiation) that can affect fertility. Our urologists will discuss fertility preservation options before any procedure.

04 What is the recovery time after orchiectomy?

Most patients return to light daily activities within one to two weeks. Strenuous physical activity and heavy lifting should be avoided for four to six weeks. The procedure is performed under general anesthesia and is typically an outpatient surgery, meaning you go home the same day.

05 How often will I need follow-up appointments after treatment?

Surveillance schedules depend on cancer type and stage but typically involve physical exams, tumor marker blood tests, and imaging studies every few months for the first two years, then gradually decreasing in frequency. Most surveillance protocols extend five to ten years after treatment.

06 Can testicular cancer come back after treatment?

Recurrence is possible but uncommon when treated early. Stage I seminomas have a recurrence rate of approximately 15-20% with surveillance alone, which is why regular follow-up is essential. Even when recurrence occurs, testicular cancer remains highly curable with additional treatment.

07 Is a testicular prosthesis available after surgery?

Yes. A saline-filled testicular prosthesis can be placed during or after the orchiectomy to restore a natural appearance and feel. Our urologists will discuss this option with you during your preoperative consultation if you are interested.

Location129 W Hibiscus Blvd, Suite D
Melbourne , FL, 32901

Schedule Your Consultation

Scientific References

  1. PubMed (PMID: 29261439) - Cheng L, et al. Testicular cancer. Nat Rev Dis Primers. 2018;4(1):29. Comprehensive review of testicular cancer biology, diagnosis, and management.
  2. PubMed (PMID: 30113631) - Gilligan T, et al. Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17(12):1529-1554. Evidence-based guidelines for testicular cancer staging and treatment.
  3. PubMed (PMID: 27997569) - Rajpert-De Meyts E, et al. Testicular germ cell tumours. Lancet. 2016;387(10029):1762-1774. Epidemiology, risk factors, and pathogenesis of testicular germ cell tumors.
  4. PubMed (PMID: 31566943) - Dieckmann KP, et al. Serum tumour markers in testicular germ cell tumours: frequencies of elevated levels and extents of marker elevation. J Cancer Res Clin Oncol. 2019;145(12):3075-3083. Role of tumor markers AFP, hCG, and LDH in diagnosis and surveillance.
  5. American Urological Association (AUA) - Guidelines for Early-Stage Testicular Cancer Management. Evidence-based recommendations for surveillance and adjuvant therapy after orchiectomy.